Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia.
Stow
Patricia
P
Department of Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
Key
Laura
L
Chen
Xiaohua
X
Pan
Qiulu
Q
Neale
Geoffrey A
GA
Coustan-Smith
Elaine
E
Mullighan
Charles G
CG
Zhou
Yinmei
Y
Pui
Ching-Hon
CH
Campana
Dario
D
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D018365:Neoplasm, Residual; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D011379:Prognosis; D012008:Recurrence; D012074:Remission Induction; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors